IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Darwin Global Management, Ltd.

Q3 2024 Holdings

Filed 2024-11-14 | 5 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Insmed Inc(INSM)COM PAR $.01457669307$766.3M10,497,27762.3%
Vaxcyte Inc(PCVX)COM92243G108$251.2M2,198,18720.4%
Geron Corp(GERN)COM374163103$100.1M22,038,7738.1%
Keros Therapeutics Inc(KROS)COM492327101$88.5M1,523,7327.2%
Summit Therapeutics Inc(SMMT)COM86627T108$23.8M1,084,8801.9%